healthcare affordability Archives

How Online Generic Medications Could Benefit the Hispanic Community in the U.S.

Brian RogersJune 6, 20240175 views

The United States, home to approximately 331 million people, includes a significant Hispanic or Latino community, comprising 21.9% of the population when accounting for undocumented immigrants. This demographic familiarity with Mexico’s lenient over-the-counter medication policies suggests a need for similar reforms in the U.S. Allowing online access to verified generic pharmaceuticals could reduce healthcare costs, increase accessibility, and empower consumers, aligning better with the principles of freedom and equality enshrined in American founding documents.

Reducing Family Healthcare Costs with Indian Generic Medications

Brian RogersJune 2, 20240136 views

In the current healthcare landscape of the United States, families are increasingly burdened by high medical costs, which include not only the prices of prescription drugs but also associated costs such as doctor’s visits and time off work. For a family of four, turning to online generic pharmacies, particularly those based in India, can offer substantial cost savings and convenience. This article explores how a family can save money by using these alternatives compared to traditional U.S. healthcare purchasing methods. By purchasing WHO-certified generic medications from reputable Indian online pharmacies, families can significantly reduce their healthcare expenses, eliminating unnecessary costs and improving access to essential medications.

The Cost of Corporate Protectionism: Denying Americans Affordable Indian Generics

Brian RogersJune 2, 20240153 views

The United States is currently grappling with significant economic disparities, a shrinking middle class, and an influx of illegal immigrants, all contributing to the widening gap in healthcare accessibility. As a result, many Americans face conditions comparable to those in developing nations when it comes to healthcare affordability. In this context, the pharmaceutical industry’s influence on U.S. healthcare policies has led to corporate protectionism that prioritizes profits over public health. This article explores how this protectionism denies Americans access to affordable Indian generics, despite the U.S. funding the World Health Organization (WHO) to distribute these medications globally.